Item 8.01 Other Events

ATM Sales

IDEAYA Biosciences, Inc. (the "Company") reports that, as of January 15, 2021, it had sold 3,109,890 shares of its common stock for aggregate gross proceeds of $49,999,986 at a weighted average sales price of approximately $16.08 per share under its at-the-market offering pursuant to an Open Market Sale Agreement (the "Sales Agreement") with Jefferies LLC ("Jefferies"), as sales agent. Pursuant to the Sales Agreement, Jefferies, as sales agent, receives a commission of 3.0% of the aggregate gross proceeds that the Company receives from each sale of its shares of common stock sold under the Sales Agreement.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses